We are the problem when we would rather take the injection or the pill than make the lifestyle change. I am fortunate that I ...

Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...

Shore Capital, which covers hVIVO, sees plenty of upside. The broker notes that the company’s cash generation, revenue visibility, and profitability make it an outlier in healthcare, where many firms ...

Nischal Maheshwari, CEO and Market Expert, feels the market is close to the bottom and expects clarity post the resolution of ...

Taiho Pharmaceutical has agreed to acquire Swiss-based antibody-drug-conjugate (ADC) specialist Araris Biotech for up to ...

In the week when U.S. President Donald Trump sounded alarm bells about Ireland “stealing the U.S. pharmaceutical industry” ...

Artificial intelligence continues stirring things up in chemistry. To wit: YC-backed Cambridge, U.K.-based ReactWise is using ...

Jyotivardhan Jaipuria, Founder & MD, Valentis Advisors, is more optimistic about the market after the correction. He believes ...

The new $5.3 billion deal with the Swiss pharma giant gives Zealand a significant partner to advance its amylin analog obesity shot and create a new combination product.

If you ask any Missouri family what's stretching their wallets the most, you'll likely hear the same thing: higher prices on everything.

The first round of $175,000 in Big Pharma funds goes to local agencies devoted to education, prevention, intervention, harm ...

Novo Nordisk is a great pick to buy with the stock near its 52-week low. Vertex Pharmaceuticals is helping patients and ...